Liver Disease in Women

Karen Krok, Ayman Koteish

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The cyclical hormonal changes that occur in women are often a reason to exclude females from clinical and basic research studies. However, these very hormones may play a role in the pathogenesis of diseases in women. For this reason, it is important to consider gender when evaluating a patient. In hepatology, gender and sex hormones play a role in the epidemiology of autoimmune diseases (autoimmune hepatitis and primary biliary cirrhosis), the effect of alcohol on the liver, the development of benign and malignant liver tumors, and of course on pregnancy-related liver diseases. This chapter discusses the impact of female gender on the development and/or progression of specific liver diseases. Liver diseases that may coincide with, but are unrelated to, pregnancy usually do not result in significant maternal or fetal mortality. However, in the case of pregnancy-specific liver disease, it is essential to accurately determine the gestational age, and the timing of the disease onset. Liver diseases unique to pregnancy include ovarian hyperstimulation syndrome (OHSS), hyperemesis gravidarum (HG), intrahepatic cholestasis of pregnancy (ICP), acute fatty liver of pregnancy (AFLP), hemolysis-elevated liver enzymes-low platelets (HELLP) syndrome, and hepatic hemorrhage or rupture. OHSS is a potentially fatal iatrogenic complication associated with ovulation-induction therapy. The basic pathophysiologic hallmark of OHSS is an increase in capillary permeability that results in the leakage or exudation of protein-rich fluid from the ovaries or peritoneal surface to the third space compartments.

Original languageEnglish (US)
Title of host publicationPrinciples of Gender-Specific Medicine
PublisherElsevier Inc.
Pages331-344
Number of pages14
ISBN (Print)9780123742711
DOIs
StatePublished - Dec 1 2010

Fingerprint

Liver Diseases
Ovarian Hyperstimulation Syndrome
Pregnancy
Liver
Hyperemesis Gravidarum
Fetal Mortality
Autoimmune Hepatitis
Biliary Liver Cirrhosis
Ovulation Induction
Maternal Mortality
Capillary Permeability
Gonadal Steroid Hormones
Gastroenterology
Hemolysis
Autoimmune Diseases
Gestational Age
Rupture
Ovary
Epidemiology
Blood Platelets

All Science Journal Classification (ASJC) codes

  • Dentistry(all)
  • Medicine(all)

Cite this

Krok, K., & Koteish, A. (2010). Liver Disease in Women. In Principles of Gender-Specific Medicine (pp. 331-344). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-374271-1.00031-9
Krok, Karen ; Koteish, Ayman. / Liver Disease in Women. Principles of Gender-Specific Medicine. Elsevier Inc., 2010. pp. 331-344
@inbook{349cfef46fda4342891d44d7ec6022dd,
title = "Liver Disease in Women",
abstract = "The cyclical hormonal changes that occur in women are often a reason to exclude females from clinical and basic research studies. However, these very hormones may play a role in the pathogenesis of diseases in women. For this reason, it is important to consider gender when evaluating a patient. In hepatology, gender and sex hormones play a role in the epidemiology of autoimmune diseases (autoimmune hepatitis and primary biliary cirrhosis), the effect of alcohol on the liver, the development of benign and malignant liver tumors, and of course on pregnancy-related liver diseases. This chapter discusses the impact of female gender on the development and/or progression of specific liver diseases. Liver diseases that may coincide with, but are unrelated to, pregnancy usually do not result in significant maternal or fetal mortality. However, in the case of pregnancy-specific liver disease, it is essential to accurately determine the gestational age, and the timing of the disease onset. Liver diseases unique to pregnancy include ovarian hyperstimulation syndrome (OHSS), hyperemesis gravidarum (HG), intrahepatic cholestasis of pregnancy (ICP), acute fatty liver of pregnancy (AFLP), hemolysis-elevated liver enzymes-low platelets (HELLP) syndrome, and hepatic hemorrhage or rupture. OHSS is a potentially fatal iatrogenic complication associated with ovulation-induction therapy. The basic pathophysiologic hallmark of OHSS is an increase in capillary permeability that results in the leakage or exudation of protein-rich fluid from the ovaries or peritoneal surface to the third space compartments.",
author = "Karen Krok and Ayman Koteish",
year = "2010",
month = "12",
day = "1",
doi = "10.1016/B978-0-12-374271-1.00031-9",
language = "English (US)",
isbn = "9780123742711",
pages = "331--344",
booktitle = "Principles of Gender-Specific Medicine",
publisher = "Elsevier Inc.",
address = "United States",

}

Krok, K & Koteish, A 2010, Liver Disease in Women. in Principles of Gender-Specific Medicine. Elsevier Inc., pp. 331-344. https://doi.org/10.1016/B978-0-12-374271-1.00031-9

Liver Disease in Women. / Krok, Karen; Koteish, Ayman.

Principles of Gender-Specific Medicine. Elsevier Inc., 2010. p. 331-344.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Liver Disease in Women

AU - Krok, Karen

AU - Koteish, Ayman

PY - 2010/12/1

Y1 - 2010/12/1

N2 - The cyclical hormonal changes that occur in women are often a reason to exclude females from clinical and basic research studies. However, these very hormones may play a role in the pathogenesis of diseases in women. For this reason, it is important to consider gender when evaluating a patient. In hepatology, gender and sex hormones play a role in the epidemiology of autoimmune diseases (autoimmune hepatitis and primary biliary cirrhosis), the effect of alcohol on the liver, the development of benign and malignant liver tumors, and of course on pregnancy-related liver diseases. This chapter discusses the impact of female gender on the development and/or progression of specific liver diseases. Liver diseases that may coincide with, but are unrelated to, pregnancy usually do not result in significant maternal or fetal mortality. However, in the case of pregnancy-specific liver disease, it is essential to accurately determine the gestational age, and the timing of the disease onset. Liver diseases unique to pregnancy include ovarian hyperstimulation syndrome (OHSS), hyperemesis gravidarum (HG), intrahepatic cholestasis of pregnancy (ICP), acute fatty liver of pregnancy (AFLP), hemolysis-elevated liver enzymes-low platelets (HELLP) syndrome, and hepatic hemorrhage or rupture. OHSS is a potentially fatal iatrogenic complication associated with ovulation-induction therapy. The basic pathophysiologic hallmark of OHSS is an increase in capillary permeability that results in the leakage or exudation of protein-rich fluid from the ovaries or peritoneal surface to the third space compartments.

AB - The cyclical hormonal changes that occur in women are often a reason to exclude females from clinical and basic research studies. However, these very hormones may play a role in the pathogenesis of diseases in women. For this reason, it is important to consider gender when evaluating a patient. In hepatology, gender and sex hormones play a role in the epidemiology of autoimmune diseases (autoimmune hepatitis and primary biliary cirrhosis), the effect of alcohol on the liver, the development of benign and malignant liver tumors, and of course on pregnancy-related liver diseases. This chapter discusses the impact of female gender on the development and/or progression of specific liver diseases. Liver diseases that may coincide with, but are unrelated to, pregnancy usually do not result in significant maternal or fetal mortality. However, in the case of pregnancy-specific liver disease, it is essential to accurately determine the gestational age, and the timing of the disease onset. Liver diseases unique to pregnancy include ovarian hyperstimulation syndrome (OHSS), hyperemesis gravidarum (HG), intrahepatic cholestasis of pregnancy (ICP), acute fatty liver of pregnancy (AFLP), hemolysis-elevated liver enzymes-low platelets (HELLP) syndrome, and hepatic hemorrhage or rupture. OHSS is a potentially fatal iatrogenic complication associated with ovulation-induction therapy. The basic pathophysiologic hallmark of OHSS is an increase in capillary permeability that results in the leakage or exudation of protein-rich fluid from the ovaries or peritoneal surface to the third space compartments.

UR - http://www.scopus.com/inward/record.url?scp=84882554967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882554967&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-374271-1.00031-9

DO - 10.1016/B978-0-12-374271-1.00031-9

M3 - Chapter

AN - SCOPUS:84882554967

SN - 9780123742711

SP - 331

EP - 344

BT - Principles of Gender-Specific Medicine

PB - Elsevier Inc.

ER -

Krok K, Koteish A. Liver Disease in Women. In Principles of Gender-Specific Medicine. Elsevier Inc. 2010. p. 331-344 https://doi.org/10.1016/B978-0-12-374271-1.00031-9